San Diego, October 3, 2019 - Hilton Torrey Pines
This year our annual San Diego symposium focuses on advanced strategies to progress translational oncology research and preclinical drug development.
Cancer research continues to be revolutionized by novel development and treatment approaches across oncology and immuno-oncology. As widespread innovation and advanced strategies continue to enhance preclinical models and technologies, the next generation of anticancer agents can continue to bring improved patient benefits.
The symposium will bring together oncology and immuno-oncology R&D and preclinical teams from pharmaceutical and biotech companies to facilitate cross discipline discussions on current techniques, and how to move forward with future approaches.
Discussion Topics Include:
- New technologies for treating hematological malignancies
- Novel targets for next generation oncology and immuno-oncology agents
- The future of immunocompetent and humanized models for immunotherapy assessment
Presentation & Speakers
Attendance is free, but seats are limited, reserve your space by submitting the registration form today!